Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StockTalk | Cannabis Report: Quarterly reporting bonanza

Jonathon Brown Jonathon Brown, The Market Online
0 Comments| May 16, 2025

{{labelSign}}  Favorites
{{errorMessage}}

(Source: File)

This Vancouver-based cannabis processor announced a major commercial milestone with the launch of 20 new product listings across Canada, spanning four key product categories— vapes, softgels, oils, and infused prerolls— marking its first foray into the Québec market.

Click to enlarge
(Source: Nextleaf Solutions Ltd.)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Organigram announced its financial results for its Q2 of fiscal 2025, showing off notable growth across various metrics

2 | Auxly Reports 29 per cent net revenue increase in Q1 2025

3 | MediPharm Labs announces 11 per cent revenue increase in Q1 2025

4 | Apollo Capital warns MediPharm shareholders of continued value destruction and insolvency risk following “disastrous” Q1 financial results

Click to enlarge

Top Cannabis Stocks May 09 to May 15, 2025

1. T.TLRY | 4,701 views | Tilray Brands Inc.
2. T.LABS | 4,276 views | Medipharm Labs Corp.
3.C.CURA | 3,421 views | Curaleaf Holdings Inc.
4. T.WEED | 2,504 views | Canopy Growth Corp.
5. T.OGI | 396 views | Organigram Holdings Inc.
6. T.ACB | 392 views | Aurora Cannabis Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.




{{labelSign}}  Favorites
{{errorMessage}}